These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
839 related articles for article (PubMed ID: 15363819)
1. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients. Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819 [TBL] [Abstract][Full Text] [Related]
2. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury. Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161 [TBL] [Abstract][Full Text] [Related]
3. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases. Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906 [TBL] [Abstract][Full Text] [Related]
4. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers. Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261 [TBL] [Abstract][Full Text] [Related]
5. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Fujiwara M; Muragaki Y; Ooshima A Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739 [TBL] [Abstract][Full Text] [Related]
6. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis. Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957 [TBL] [Abstract][Full Text] [Related]
7. Ginkgo biloba extract prevents glucose-induced accumulation of ECM in rat mesangial cells. Ji L; Yin XX; Wu ZM; Wang JY; Lu Q; Gao YY Phytother Res; 2009 Apr; 23(4):477-85. PubMed ID: 19003945 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts. Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Ohnishi K; Takagi M; Kurokawa Y; Satomi S; Konttinen YT Lab Invest; 1998 Sep; 78(9):1077-87. PubMed ID: 9759652 [TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction. Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815 [TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464 [TBL] [Abstract][Full Text] [Related]
12. The membrane-type-matrix metalloproteinase/matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodeling in loose total-hip prostheses. Takagi M; Santavirta S; Ida H; Ishii M; Akimoto K; Saotome K; Konttinen YT Lab Invest; 1998 Jun; 78(6):735-42. PubMed ID: 9645764 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Baker EA; Bergin FG; Leaper DJ Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431 [TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats. Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079 [TBL] [Abstract][Full Text] [Related]
15. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Tang Y; Kesavan P; Nakada MT; Yan L Mol Cancer Res; 2004 Feb; 2(2):73-80. PubMed ID: 14985463 [TBL] [Abstract][Full Text] [Related]
16. Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer. Morikawa A; Ohara N; Xu Q; Nakabayashi K; DeManno DA; Chwalisz K; Yoshida S; Maruo T Hum Reprod; 2008 Apr; 23(4):944-51. PubMed ID: 18281245 [TBL] [Abstract][Full Text] [Related]
17. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture. Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974 [TBL] [Abstract][Full Text] [Related]
18. Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection. Ishii T; Asuwa N Hum Pathol; 2000 Jun; 31(6):640-6. PubMed ID: 10872655 [TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis. Papakonstantinou E; Dionyssopoulos A; Aletras AJ; Pesintzaki C; Minas A; Karakiulakis G J Am Acad Dermatol; 2004 Oct; 51(4):526-33. PubMed ID: 15389186 [TBL] [Abstract][Full Text] [Related]
20. The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14. Filanti C; Dickson GR; Di Martino D; Ulivi V; Sanguineti C; Romano P; Palermo C; Manduca P J Bone Miner Res; 2000 Nov; 15(11):2154-68. PubMed ID: 11092396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]